PT794790E - Libertacao localizada de factores que aumentam a sobrevivencia de celulas transplantadas - Google Patents
Libertacao localizada de factores que aumentam a sobrevivencia de celulas transplantadasInfo
- Publication number
- PT794790E PT794790E PT95943823T PT95943823T PT794790E PT 794790 E PT794790 E PT 794790E PT 95943823 T PT95943823 T PT 95943823T PT 95943823 T PT95943823 T PT 95943823T PT 794790 E PT794790 E PT 794790E
- Authority
- PT
- Portugal
- Prior art keywords
- microspheres
- egf
- hepatocytes
- cells
- survival
- Prior art date
Links
- 230000004083 survival effect Effects 0.000 title abstract 3
- 239000004005 microsphere Substances 0.000 abstract 5
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 abstract 4
- 102000009024 Epidermal Growth Factor Human genes 0.000 abstract 3
- 101800003838 Epidermal growth factor Proteins 0.000 abstract 3
- 210000004027 cell Anatomy 0.000 abstract 3
- 229940116977 epidermal growth factor Drugs 0.000 abstract 3
- 210000003494 hepatocyte Anatomy 0.000 abstract 3
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- 230000006820 DNA synthesis Effects 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000002870 angiogenesis inducing agent Substances 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 239000003102 growth factor Substances 0.000 abstract 1
- 239000007943 implant Substances 0.000 abstract 1
- 238000002513 implantation Methods 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000011694 lewis rat Methods 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 210000000713 mesentery Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/407—Liver; Hepatocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
- C12N5/0075—General culture methods using substrates using microcarriers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2531/00—Microcarriers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/358,235 US6281015B1 (en) | 1994-12-16 | 1994-12-16 | Localized delivery of factors enhancing survival of transplanted cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT794790E true PT794790E (pt) | 2002-09-30 |
Family
ID=23408836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT95943823T PT794790E (pt) | 1994-12-16 | 1995-12-14 | Libertacao localizada de factores que aumentam a sobrevivencia de celulas transplantadas |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6281015B1 (pt) |
| EP (1) | EP0794790B1 (pt) |
| JP (2) | JP4361134B2 (pt) |
| AT (1) | ATE216255T1 (pt) |
| CA (1) | CA2207286C (pt) |
| DE (1) | DE69526448T2 (pt) |
| DK (1) | DK0794790T3 (pt) |
| ES (1) | ES2176359T3 (pt) |
| PT (1) | PT794790E (pt) |
| WO (1) | WO1996018411A1 (pt) |
Families Citing this family (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050033132A1 (en) | 1997-03-04 | 2005-02-10 | Shults Mark C. | Analyte measuring device |
| ATE306942T1 (de) * | 1999-09-16 | 2005-11-15 | Novo Nordisk As | Zusammensetzung zur in-vitro befruchtung |
| US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
| US20070141107A1 (en) * | 2000-03-15 | 2007-06-21 | Orbusneich Medical, Inc. | Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device |
| CA2400319C (en) | 2000-03-15 | 2008-09-16 | Orbus Medical Technologies Inc. | Coating that promotes endothelial cell adherence |
| US8460367B2 (en) * | 2000-03-15 | 2013-06-11 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
| US20030229393A1 (en) * | 2001-03-15 | 2003-12-11 | Kutryk Michael J. B. | Medical device with coating that promotes cell adherence and differentiation |
| US20070055367A1 (en) * | 2000-03-15 | 2007-03-08 | Orbus Medical Technologies, Inc. | Medical device with coating that promotes endothelial cell adherence and differentiation |
| US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
| US6719970B1 (en) * | 2000-07-10 | 2004-04-13 | Alkermes Controlled Therapeutics, Inc. | Method of generating cartilage |
| WO2002016557A2 (en) * | 2000-08-21 | 2002-02-28 | Rice University | Tissue engineering scaffolds promoting matrix protein production |
| US9080146B2 (en) | 2001-01-11 | 2015-07-14 | Celonova Biosciences, Inc. | Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface |
| US20030152630A1 (en) * | 2001-05-11 | 2003-08-14 | Ng Steven Y. | PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers |
| US6590059B2 (en) * | 2001-05-11 | 2003-07-08 | Ap Pharma, Inc. | Bioerodible polyorthoesters from dioxolane-based diketene acetals |
| WO2003007782A2 (en) * | 2001-06-29 | 2003-01-30 | Medgraft Microtech, Inc. | Biodegradable injectable implants and related methods of manufacture and use |
| US6524606B1 (en) * | 2001-11-16 | 2003-02-25 | Ap Pharma, Inc. | Bioerodible polyorthoesters containing amine groups |
| US7613491B2 (en) | 2002-05-22 | 2009-11-03 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
| US8364229B2 (en) | 2003-07-25 | 2013-01-29 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
| US20040209361A1 (en) * | 2003-04-18 | 2004-10-21 | Hemperly John J. | UV-cross-linked PVA-based polymer particles for cell culture |
| US20040209360A1 (en) * | 2003-04-18 | 2004-10-21 | Keith Steven C. | PVA-based polymer coating for cell culture |
| US9763609B2 (en) | 2003-07-25 | 2017-09-19 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
| US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
| US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
| US20080119703A1 (en) | 2006-10-04 | 2008-05-22 | Mark Brister | Analyte sensor |
| US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
| US20050214377A1 (en) * | 2004-03-24 | 2005-09-29 | Sanjay Mistry | Microparticles for cell delivery |
| US7691381B2 (en) * | 2004-04-15 | 2010-04-06 | Allergan, Inc. | Stabilized biodegradable neurotoxin implants |
| EP2946666B1 (en) * | 2004-04-30 | 2017-11-15 | OrbusNeich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods of using same |
| US7351423B2 (en) | 2004-09-01 | 2008-04-01 | Depuy Spine, Inc. | Musculo-skeletal implant having a bioactive gradient |
| US9107850B2 (en) | 2004-10-25 | 2015-08-18 | Celonova Biosciences, Inc. | Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
| US20210299056A9 (en) | 2004-10-25 | 2021-09-30 | Varian Medical Systems, Inc. | Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods |
| US9114162B2 (en) | 2004-10-25 | 2015-08-25 | Celonova Biosciences, Inc. | Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same |
| JP4885866B2 (ja) | 2004-10-25 | 2012-02-29 | セロノヴァ バイオサイエンスィズ ジャーマニー ゲーエムベーハー | 治療適用および／または診断適用のための充填可能なポリホスファゼン含有粒子、ならびにその調製方法および使用方法 |
| EP1824417A2 (en) * | 2004-12-08 | 2007-08-29 | Pervasis Therapeutics, Inc. | Materials and methods for treating and managing plaque disease |
| JP5174656B2 (ja) * | 2005-04-21 | 2013-04-03 | マサチューセッツ インスティテュート オブ テクノロジー | 同系または非同系の細胞、組織または器官を含む、外因性免疫原および内因性免疫原に対する免疫応答を改変するための材料および方法 |
| US20060257355A1 (en) * | 2005-05-10 | 2006-11-16 | Abiomed, Inc. | Impregnated polymer compositions and devices using them |
| US20090035346A1 (en) | 2005-06-21 | 2009-02-05 | Pervasis Therpeutics, Inc. | Methods and Compositions for Enhancing Vascular Access |
| CA2615491C (en) | 2005-07-19 | 2016-11-29 | Stemgen S.P.A. | Inhibition of the tumorigenic potential of tumor stem cells by lif and bmps |
| AU2006305989B2 (en) | 2005-10-26 | 2013-10-24 | Genesis Technologies Limited | Acellular bioabsorbable tissue regeneration matrices produced by incubating acellular blood products |
| US20100204783A1 (en) * | 2005-12-06 | 2010-08-12 | Helen Marie Nugent | Methods and compositions for enhancing vascular access |
| WO2007146319A2 (en) * | 2006-06-13 | 2007-12-21 | Symphony Medical, Inc. | Methods and apparatus for using polymer-based beads and hydrogels for cardiac applications |
| CN101583367B (zh) * | 2006-11-07 | 2013-05-01 | 夏尔再生医学公司 | 用于治疗和控制血管生成介导的疾病的材料和方法 |
| CA2681412A1 (en) | 2007-03-26 | 2008-10-02 | Dexcom, Inc. | Analyte sensor |
| US20200037874A1 (en) | 2007-05-18 | 2020-02-06 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
| EP2152350A4 (en) | 2007-06-08 | 2013-03-27 | Dexcom Inc | INTEGRATED MEDICINE DELIVERY DEVICE FOR USE WITH A CONTINUOUS ANALYZING SUBSTANCE SENSOR |
| US20100185156A1 (en) * | 2007-06-13 | 2010-07-22 | Pervasis Therapeutics, Inc. | Methods and Devices for Minimally-Invasive Delivery of Cell-Containing Flowable Compositions |
| JP2010536373A (ja) | 2007-08-23 | 2010-12-02 | イントレキソン コーポレーション | 疾患を診断するための方法および組成物 |
| CA2715080C (en) | 2007-09-28 | 2021-09-28 | Intrexon Corporation | Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof |
| EP4098177A1 (en) | 2007-10-09 | 2022-12-07 | DexCom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
| US8583204B2 (en) | 2008-03-28 | 2013-11-12 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
| US20090247855A1 (en) | 2008-03-28 | 2009-10-01 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
| US11730407B2 (en) | 2008-03-28 | 2023-08-22 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
| US8682408B2 (en) | 2008-03-28 | 2014-03-25 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
| KR20130056348A (ko) * | 2008-09-25 | 2013-05-29 | 인비보 테라퓨틱스 코포레이션 | 척수 외상, 염증, 및 면역 질환: 치료제의 국소적 제어 방출 |
| US20100272816A1 (en) * | 2009-04-27 | 2010-10-28 | Wolfgang Rudinger | Microcapsules comprising liver cells and erythropoietin, methods for preparing said microcapsules and methods for treating a patient comprising applying said microcapsules to the patient |
| US8492339B2 (en) * | 2009-10-26 | 2013-07-23 | Empire Technology Development Llc | Angiogenesis promoted by caged growth factors |
| CA2780294C (en) | 2009-11-09 | 2018-01-16 | Spotlight Technology Partners Llc | Polysaccharide based hydrogels |
| CA2780274C (en) | 2009-11-09 | 2018-06-26 | Spotlight Technology Partners Llc | Fragmented hydrogels |
| WO2012142502A2 (en) | 2011-04-15 | 2012-10-18 | Dexcom Inc. | Advanced analyte sensor calibration and error detection |
| US8883503B2 (en) | 2011-06-23 | 2014-11-11 | Indian Institute Of Technology Kanpur | Hydrogel scaffolds for tissue engineering |
| US8753309B2 (en) | 2011-06-24 | 2014-06-17 | The Invention Science Fund I, Llc | Device, system, and method including micro-patterned cell treatment array |
| US20130053666A1 (en) | 2011-08-26 | 2013-02-28 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
| US9381112B1 (en) | 2011-10-06 | 2016-07-05 | William Eric Sponsell | Bleb drainage device, ophthalmological product and methods |
| KR102039494B1 (ko) | 2011-12-22 | 2019-11-01 | 라이프 테크놀로지스 코포레이션 | 세포 배양 배지 및 방법 |
| US8632489B1 (en) | 2011-12-22 | 2014-01-21 | A. Mateen Ahmed | Implantable medical assembly and methods |
| US9788765B2 (en) | 2012-09-28 | 2017-10-17 | Dexcom, Inc. | Zwitterion surface modifications for continuous sensors |
| JP6983765B2 (ja) | 2015-12-30 | 2021-12-17 | デックスコム・インコーポレーテッド | 分析物センサのための酵素固定化接着層 |
| US11943876B2 (en) | 2017-10-24 | 2024-03-26 | Dexcom, Inc. | Pre-connected analyte sensors |
| US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
| WO2019222856A1 (en) | 2018-05-24 | 2019-11-28 | Nureva Inc. | Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones |
| SG11202005947RA (en) | 2018-05-24 | 2020-07-29 | Celanese Eva Performance Polymers Corp | Implantable device for sustained release of a macromolecular drug compound |
| WO2019226519A1 (en) | 2018-05-24 | 2019-11-28 | Celanese EVA Performance Polymers Corporation | Implantable device for sustained release of a macromolecular drug compound |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1995970A (en) | 1931-04-04 | 1935-03-26 | Du Pont | Polymeric lactide resin |
| US2609347A (en) | 1948-05-27 | 1952-09-02 | Wilson Christopher Lumley | Method of making expanded polyvinyl alcohol-formaldehyde reaction product and product resulting therefrom |
| US2664367A (en) | 1949-09-19 | 1953-12-29 | Wilson Christopher Lumley | Plasticized sponge material and method of making same |
| US2664366A (en) | 1949-09-19 | 1953-12-29 | Wilson Christopher Lumley | Plasticized sponge material and method of making same |
| US2659935A (en) | 1950-03-18 | 1953-11-24 | Christopher L Wilson | Method of making compressed sponges |
| US2653917A (en) | 1950-06-15 | 1953-09-29 | Christopher L Wilson | Method of making an expanded material and the product resulting therefrom |
| US2676945A (en) | 1950-10-18 | 1954-04-27 | Du Pont | Condensation polymers of hydroxyacetic acid |
| US2683136A (en) | 1950-10-25 | 1954-07-06 | Du Pont | Copolymers of hydroxyacetic acid with other alcohol acids |
| US2703316A (en) | 1951-06-05 | 1955-03-01 | Du Pont | Polymers of high melting lactide |
| US2758987A (en) | 1952-06-05 | 1956-08-14 | Du Pont | Optically active homopolymers containing but one antipodal species of an alpha-monohydroxy monocarboxylic acid |
| US2846407A (en) | 1954-01-13 | 1958-08-05 | Wilson Christopher Lumley | Method of making a detergent and solvent resistant sponge material |
| DE1228416B (de) | 1957-03-04 | 1966-11-10 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung von Polyestern |
| BE634668A (pt) | 1962-07-11 | |||
| US3531561A (en) | 1965-04-20 | 1970-09-29 | Ethicon Inc | Suture preparation |
| BE744162A (fr) | 1969-01-16 | 1970-06-15 | Fuji Photo Film Co Ltd | Procede d'encapsulage |
| DE2010115A1 (de) | 1970-03-04 | 1971-09-16 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von Mikrogranulaten |
| JPS523342B2 (pt) | 1972-01-26 | 1977-01-27 | ||
| US4352883A (en) | 1979-03-28 | 1982-10-05 | Damon Corporation | Encapsulation of biological material |
| US4389330A (en) | 1980-10-06 | 1983-06-21 | Stolle Research And Development Corporation | Microencapsulation process |
| US4495174A (en) | 1982-06-21 | 1985-01-22 | Research Corporation | Anesthetic polyorganophosphazenes |
| US4440921A (en) | 1982-06-21 | 1984-04-03 | Research Corporation | Coupling of polyorganophosphazenes to carboxylic acid |
| JPS6098823A (ja) | 1983-11-02 | 1985-06-01 | 株式会社東芝 | 電力変換装置 |
| US4880622A (en) | 1986-05-20 | 1989-11-14 | Research Corporation Technologies, Inc. | Water-soluble phosphazene polymers having pharmacological applications |
| WO1990009783A1 (en) * | 1989-02-22 | 1990-09-07 | Massachusetts Institute Of Technology | Delivery system for controlled release of bioactive factors |
| US5019400A (en) | 1989-05-01 | 1991-05-28 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres |
| US4946938A (en) | 1989-08-01 | 1990-08-07 | The University Of Pittsburgh | A process for the catalytic synthesis of polyphosphazenes |
| US5362718A (en) | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
-
1994
- 1994-12-16 US US08/358,235 patent/US6281015B1/en not_active Expired - Lifetime
-
1995
- 1995-12-14 ES ES95943823T patent/ES2176359T3/es not_active Expired - Lifetime
- 1995-12-14 JP JP51927596A patent/JP4361134B2/ja not_active Expired - Fee Related
- 1995-12-14 WO PCT/US1995/016356 patent/WO1996018411A1/en active IP Right Grant
- 1995-12-14 EP EP95943823A patent/EP0794790B1/en not_active Expired - Lifetime
- 1995-12-14 DK DK95943823T patent/DK0794790T3/da active
- 1995-12-14 PT PT95943823T patent/PT794790E/pt unknown
- 1995-12-14 AT AT95943823T patent/ATE216255T1/de active
- 1995-12-14 CA CA002207286A patent/CA2207286C/en not_active Expired - Fee Related
- 1995-12-14 DE DE69526448T patent/DE69526448T2/de not_active Expired - Lifetime
-
2007
- 2007-08-27 JP JP2007220401A patent/JP2008011863A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2207286C (en) | 2003-10-07 |
| WO1996018411A1 (en) | 1996-06-20 |
| JP2008011863A (ja) | 2008-01-24 |
| DE69526448D1 (de) | 2002-05-23 |
| JPH10510816A (ja) | 1998-10-20 |
| EP0794790A1 (en) | 1997-09-17 |
| ATE216255T1 (de) | 2002-05-15 |
| CA2207286A1 (en) | 1996-06-20 |
| EP0794790B1 (en) | 2002-04-17 |
| DK0794790T3 (da) | 2002-07-22 |
| DE69526448T2 (de) | 2002-11-07 |
| ES2176359T3 (es) | 2002-12-01 |
| JP4361134B2 (ja) | 2009-11-11 |
| US6281015B1 (en) | 2001-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT794790E (pt) | Libertacao localizada de factores que aumentam a sobrevivencia de celulas transplantadas | |
| DE69330562T2 (de) | Biotherapeutische mikrosphären beschichtet mit zellen | |
| ATE297169T1 (de) | Auffindbare künstliche bioimplantate | |
| Navsaria et al. | Culturing skin in vitro for wound therapy | |
| MY113488A (en) | Compounds with growth hormone releasing properties | |
| IL176268A0 (en) | Use of alginate matrices to control cell growth | |
| HK1077525A1 (en) | Augentation of organ function | |
| AU2369595A (en) | In vitro growth of functional islets of langerhans and in vivo uses thereof | |
| IL115721A0 (en) | Methods and compositions for the modulation of cell proliferation and wound healing | |
| CA2031532A1 (en) | Method for implanting large volumes of cells on polymeric matrices | |
| EP1652538A3 (en) | Autologous platelet gel on a stent graft | |
| DE3751843D1 (de) | Herstellung von körperorganen durch kontroliertes zellwachstum auf künstlicher matrix | |
| CA2090719A1 (en) | In vivo delivery of active factors by co-cultured cell implants | |
| ATE288932T1 (de) | Neue biomaterialien | |
| DE60303705D1 (de) | Beschichteter Stent für die Freisetzung aktiver Substanzen | |
| CN101856517B (zh) | 基于组织工程材料的黑素细胞的培养方法及其应用 | |
| IT1307829B1 (it) | Protesi dentale con mezzi per il rilascio di farmaci o fattorispecifici atti ad impedire l'insorgenza di infezioni e/o promuovere | |
| US20130149667A1 (en) | Multiphase tissue complex scaffolds | |
| HK1048498A1 (zh) | 自然殺傷細胞的增殖方法 | |
| Kukita et al. | Heat-treated osteoblastic cell (ROS17/2.8)-conditioned medium induces the formation of osteoclast-like cells | |
| NZ506510A (en) | A permanent skin replacement comprising allogenic epithelial cells cultured in vitro and autologous epithelial cells | |
| DE60115235T2 (de) | Aus gewebe aufgebauter stent | |
| AU3844995A (en) | Implantable device for administration of active substances to plants | |
| US9259445B2 (en) | Integrated implant system (IIS) biocompatible, biodegradable and bioactive, comprising a biocompatible sterile porous polymeric matrix and a gel, integrating in situ the tridimensional matrix structure | |
| DE69737455D1 (de) | Definierte systeme zur kultivieurng epithelialer zellen und anwendung derselben |